Marrone Bio (MBII) Stock Alert: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Marrone Bio Innovations, Inc. Is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Marrone Bio Innovations, Inc. (NASDAQ: MBII) to Bioceres Crop Solutions Corp. is fair to Marrone Bio shareholders. Under the terms of the proposed transaction, each share of Marrone Bio common stock will be exchanged at closing for ordinary shares of Bioceres at a fixed ratio of 0.088.

Halper Sadeh encourages Marrone Bio shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at [phone] or [e-mail] or [e-mail].

The investigation concerns whether Marrone Bio and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Marrone Bio shareholders; (2) determine whether Bioceres is underpaying for Marrone Bio; and (3) disclose all material information necessary for Marrone Bio shareholders to adequately assess and value the merger consideration. On behalf of Marrone Bio shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

Halper Sadeh encourages Marrone Bio shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at [phone] or [e-mail] or [e-mail].

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.